Shaanxi Meili Omni-Honesty Animal Health

Shaanxi Meili Omni-Honesty Animal Health is a specialized veterinary biopharmaceutical company based in Yangling, China, focused on the development and large-scale production of high-quality livestock vaccines. The company is a strategic joint venture involving Boehringer Ingelheim, established to address the critical need for Foot-and-Mouth Disease (FMD) prevention in the Chinese market. It operates a state-of-the-art manufacturing facility that adheres to international GMP standards and utilizes advanced suspension culture and antigen purification technologies. The company's primary products include inactivated FMD vaccines for swine and cattle, contributing significantly to national animal disease control and food security. By combining global technical expertise with local market insights, Meili Omni-Honesty has become a key player in China's animal health infrastructure.